Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Comment by chrispion Nov 06, 2020 2:53pm
254 Views
Post# 31852969

RE:PMED Shareholders Update Call

RE:PMED Shareholders Update Call A big sigh of relief they're pretty much thru their growing pains and can focus on the $ now.

I'm still comforted by the fact that there is LITTLE TO NO COMPETITION for their impairment (alcohol and cannabis) and covid-19 screening technologies. What competition there is, is inferior in terms of functionality. For example, why just check workers for elevated body temperature when you can be checking for so many more symptoms of infectious disease that will help to be more precise in terms of who is infected. The moat they've built will take years for others to penetrate develop as the barriers to entry in each of those verticals is huge.

To me, they are just entering the sweet spot of deployments ("level 9" as Rahul stated). If you sat out the 50% drop from all-time highs, then now is not the time to bail. Unless you are in front of your computer every day and have a crystal ball for when news is coming and can daytrade this and be in it just prior to an announcement, exit, then repeat, well, I think you'll torture yourself as to when the next best time to get in will be.

The pain has already been dealt with their execution delays and now they are entering the period where they will be doing big deployments.

<< Previous
Bullboard Posts
Next >>